Callan Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,958
| Closed | -$353K | – | 302 |
|
|
2023
Q4 | $353K | Buy |
3,958
+1,018
| +35% | +$90.9K | 0.03% | 160 |
|
|
2023
Q3 | $215K | Sell |
2,940
-195
| -6% | -$14.2K | 0.02% | 184 |
|
|
2023
Q2 | $261K | Buy |
3,135
+500
| +19% | +$41.6K | 0.03% | 153 |
|
|
2023
Q1 | $201K | Hold |
2,635
| – | – | 0.02% | 172 |
|
|
2022
Q4 | $219K | Buy |
+2,635
| New | +$219K | 0.03% | 170 |
|